Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Dexcom history
Dexcom company history timeline
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel.
2004 Short-term sensor Dexcom's short-term sensor program was created.
April 14 2005 Dexcom announced its IPO The initial public offering (IPO) for Dexcom was announced on the NASDAQ Stock Market under DXCM.
March 27 2006 STS CGM System launched Dexcom launched the first generation continuous glucose monitor designed to help people with diabetes more conveniently and effectively manage their blood sugar levels.
Dexcom received approval of the second generation product, the Seven Continuous Glucose Monitoring System in May 2007.
September 8 2008 JDRF landmark study in CGM Study data presented by the Juvenile Diabetes Research Foundation (JDRF) at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) showed the use of CGM to be effective in the management of type 1 diabetes.
In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
November 2009 Dexcom SEVEN® PLUS CGM System launched The SEVEN® PLUS System launched as Dexcom’s third generation device designed to help people with diabetes better manage their glucose levels.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over.
In 2013, development work for integration with Insulet was discontinued.
June 2017 Dexcom Receives FDA Approval of G5 Mobile App for Android Devices Android users now have access to the free app for the Dexcom G5 Mobile CGM System.
March 2018 Dexcom G6 CGM System Granted Market Authorization The FDA permitted the marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining glucose (sugar) levels in children aged two years and older and adults with diabetes.
October 2019 Dexcom G6 Pro CGM System Granted Clearance for Healthcare Professionals' Use with Patients The FDA cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for healthcare professionals to use with their patients, ages two years and up.
February 2021 Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial Dexcom debuted their first ever Super Bowl commercial which calls for better care for people with diabetes who are still painfully pricking their fingers to measure their glucose levels.
Dexcom, Dexcom Follow, Dexcom CLARITY, and Dexcom Share are registered trademarks of Dexcom, Inc. in the United States, and may be registered in other countries. © 2022 Dexcom, Inc.
Rate how well Dexcom lives up to its initial vision.
Dexcom jobs
Do you work at Dexcom?
Is Dexcom's vision a big part of strategic planning?
Dexcom competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| NuVasive | 1997 | $1.2B | 2,800 | - |
| Baxter International | 1931 | $10.6B | 48,000 | 268 |
| Stryker | 1941 | $22.6B | 43,000 | 2,260 |
| Intersect ENT | 2003 | $106.7M | 393 | - |
| ICU Medical | 1984 | $2.4B | 9,000 | 126 |
| Tandem Diabetes Care | 2006 | $940.2M | 1,500 | 3 |
| Danaher | 1969 | $23.9B | 80,000 | 1,650 |
| Hospira | 2004 | $4.5B | 19,000 | - |
| Amgen | 1980 | $33.4B | 22,000 | 561 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 799 |
Dexcom history FAQs
Zippia gives an in-depth look into the details of Dexcom, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dexcom. The employee data is based on information from people who have self-reported their past or current employments at Dexcom. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dexcom. The data presented on this page does not represent the view of Dexcom and its employees or that of Zippia.
Dexcom may also be known as or be related to DEXCOM INC, DexCom Inc, DexCom, Inc., Dexcom and Dexcom, Inc.